世界の人工組織心臓弁市場予測（～2028年）：経皮的心臓弁、外科的心臓弁

• 英文タイトル：Global Artificial Tissue Heart Valve Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7615 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

人工組織心臓弁市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の人工組織心臓弁の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 人工組織心臓弁市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・経皮的心臓弁、外科的心臓弁 用途別セグメントは次のように区分されます。 ・大動脈弁狭窄症、大動脈弁閉鎖不全症、その他 世界の人工組織心臓弁市場の主要な市場プレーヤーは以下のとおりです。 ・Edwards Lifesciences、Medtronic、Abbott、Livanova、Boston Scientific、Cryolife、Suzhou Jiecheng Medical Technology Co., Ltd.、Labcor Laboratórios Ltda、Braile Biomédica、MicroPort Scientific Corporation、Beijing Balance Medical Technology Co., Ltd.、Myval 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、人工組織心臓弁製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な人工組織心臓弁メーカーの企業概要、2019年～2022年までの人工組織心臓弁の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な人工組織心臓弁メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別人工組織心臓弁の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの人工組織心臓弁の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での人工組織心臓弁市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および人工組織心臓弁の産業チェーンを掲載しています。 ・第13、14、15章では、人工組織心臓弁の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Edwards Lifesciences、Medtronic、Abbott、Livanova、Boston Scientific、Cryolife、Suzhou Jiecheng Medical Technology Co., Ltd.、Labcor Laboratórios Ltda、Braile Biomédica、MicroPort Scientific Corporation、Beijing Balance Medical Technology Co., Ltd.、Myval ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：経皮的心臓弁、外科的心臓弁 ・用途別分析2017年-2028年：大動脈弁狭窄症、大動脈弁閉鎖不全症、その他 ・人工組織心臓弁の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・人工組織心臓弁のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・人工組織心臓弁のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・人工組織心臓弁の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・人工組織心臓弁の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Artificial Tissue Heart Valve market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Tissue Heart Valve market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Aortic Stenosis accounting for % of the Artificial Tissue Heart Valve global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transcatheter Heart Valve segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Tissue Heart Valve include Edwards Lifesciences, Medtronic, Abbott, Livanova, and Boston Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Tissue Heart Valve market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcatheter Heart Valve
Surgical Heart Valve
Market segment by Application can be divided into
Aortic Stenosis
Aortic Regurgitation
Others
The key market players for global Artificial Tissue Heart Valve market are listed below:
Edwards Lifesciences
Medtronic
Abbott
Livanova
Boston Scientific
Cryolife
Suzhou Jiecheng Medical Technology Co., Ltd.
Labcor Laboratórios Ltda
Braile Biomédica
MicroPort Scientific Corporation
Beijing Balance Medical Technology Co., Ltd.
Myval
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Tissue Heart Valve product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Tissue Heart Valve, with price, sales, revenue and global market share of Artificial Tissue Heart Valve from 2019 to 2022.
Chapter 3, the Artificial Tissue Heart Valve competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Tissue Heart Valve breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Tissue Heart Valve market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Tissue Heart Valve.
Chapter 13, 14, and 15, to describe Artificial Tissue Heart Valve sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Artificial Tissue Heart Valve Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Tissue Heart Valve Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Transcatheter Heart Valve
1.2.3 Surgical Heart Valve
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Tissue Heart Valve Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Aortic Stenosis
1.3.3 Aortic Regurgitation
1.3.4 Others
1.4 Global Artificial Tissue Heart Valve Market Size & Forecast
1.4.1 Global Artificial Tissue Heart Valve Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artificial Tissue Heart Valve Sales in Volume (2017-2028)
1.4.3 Global Artificial Tissue Heart Valve Price (2017-2028)
1.5 Global Artificial Tissue Heart Valve Production Capacity Analysis
1.5.1 Global Artificial Tissue Heart Valve Total Production Capacity (2017-2028)
1.5.2 Global Artificial Tissue Heart Valve Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Tissue Heart Valve Market Drivers
1.6.2 Artificial Tissue Heart Valve Market Restraints
1.6.3 Artificial Tissue Heart Valve Trends Analysis
2 Manufacturers Profiles
2.1 Edwards Lifesciences
2.1.1 Edwards Lifesciences Details
2.1.2 Edwards Lifesciences Major Business
2.1.3 Edwards Lifesciences Artificial Tissue Heart Valve Product and Services
2.1.4 Edwards Lifesciences Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Artificial Tissue Heart Valve Product and Services
2.2.4 Medtronic Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Artificial Tissue Heart Valve Product and Services
2.3.4 Abbott Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Livanova
2.4.1 Livanova Details
2.4.2 Livanova Major Business
2.4.3 Livanova Artificial Tissue Heart Valve Product and Services
2.4.4 Livanova Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Artificial Tissue Heart Valve Product and Services
2.5.4 Boston Scientific Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cryolife
2.6.1 Cryolife Details
2.6.2 Cryolife Major Business
2.6.3 Cryolife Artificial Tissue Heart Valve Product and Services
2.6.4 Cryolife Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Suzhou Jiecheng Medical Technology Co., Ltd.
2.7.1 Suzhou Jiecheng Medical Technology Co., Ltd. Details
2.7.2 Suzhou Jiecheng Medical Technology Co., Ltd. Major Business
2.7.3 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Tissue Heart Valve Product and Services
2.7.4 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Labcor Laboratórios Ltda
2.8.1 Labcor Laboratórios Ltda Details
2.8.2 Labcor Laboratórios Ltda Major Business
2.8.3 Labcor Laboratórios Ltda Artificial Tissue Heart Valve Product and Services
2.8.4 Labcor Laboratórios Ltda Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Braile Biomédica
2.9.1 Braile Biomédica Details
2.9.2 Braile Biomédica Major Business
2.9.3 Braile Biomédica Artificial Tissue Heart Valve Product and Services
2.9.4 Braile Biomédica Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 MicroPort Scientific Corporation
2.10.1 MicroPort Scientific Corporation Details
2.10.2 MicroPort Scientific Corporation Major Business
2.10.3 MicroPort Scientific Corporation Artificial Tissue Heart Valve Product and Services
2.10.4 MicroPort Scientific Corporation Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Beijing Balance Medical Technology Co., Ltd.
2.11.1 Beijing Balance Medical Technology Co., Ltd. Details
2.11.2 Beijing Balance Medical Technology Co., Ltd. Major Business
2.11.3 Beijing Balance Medical Technology Co., Ltd. Artificial Tissue Heart Valve Product and Services
2.11.4 Beijing Balance Medical Technology Co., Ltd. Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Myval
2.12.1 Myval Details
2.12.2 Myval Major Business
2.12.3 Myval Artificial Tissue Heart Valve Product and Services
2.12.4 Myval Artificial Tissue Heart Valve Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artificial Tissue Heart Valve Breakdown Data by Manufacturer
3.1 Global Artificial Tissue Heart Valve Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artificial Tissue Heart Valve Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artificial Tissue Heart Valve
3.4 Market Concentration Rate
3.4.1 Top 3 Artificial Tissue Heart Valve Manufacturer Market Share in 2021
3.4.2 Top 6 Artificial Tissue Heart Valve Manufacturer Market Share in 2021
3.5 Global Artificial Tissue Heart Valve Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artificial Tissue Heart Valve Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artificial Tissue Heart Valve Market Size by Region
4.1.1 Global Artificial Tissue Heart Valve Sales in Volume by Region (2017-2028)
4.1.2 Global Artificial Tissue Heart Valve Revenue by Region (2017-2028)
4.2 North America Artificial Tissue Heart Valve Revenue (2017-2028)
4.3 Europe Artificial Tissue Heart Valve Revenue (2017-2028)
4.4 Asia-Pacific Artificial Tissue Heart Valve Revenue (2017-2028)
4.5 South America Artificial Tissue Heart Valve Revenue (2017-2028)
4.6 Middle East and Africa Artificial Tissue Heart Valve Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artificial Tissue Heart Valve Sales in Volume by Type (2017-2028)
5.2 Global Artificial Tissue Heart Valve Revenue by Type (2017-2028)
5.3 Global Artificial Tissue Heart Valve Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artificial Tissue Heart Valve Sales in Volume by Application (2017-2028)
6.2 Global Artificial Tissue Heart Valve Revenue by Application (2017-2028)
6.3 Global Artificial Tissue Heart Valve Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artificial Tissue Heart Valve Sales by Type (2017-2028)
7.2 North America Artificial Tissue Heart Valve Sales by Application (2017-2028)
7.3 North America Artificial Tissue Heart Valve Market Size by Country
7.3.1 North America Artificial Tissue Heart Valve Sales in Volume by Country (2017-2028)
7.3.2 North America Artificial Tissue Heart Valve Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artificial Tissue Heart Valve Sales by Type (2017-2028)
8.2 Europe Artificial Tissue Heart Valve Sales by Application (2017-2028)
8.3 Europe Artificial Tissue Heart Valve Market Size by Country
8.3.1 Europe Artificial Tissue Heart Valve Sales in Volume by Country (2017-2028)
8.3.2 Europe Artificial Tissue Heart Valve Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artificial Tissue Heart Valve Sales by Type (2017-2028)
9.2 Asia-Pacific Artificial Tissue Heart Valve Sales by Application (2017-2028)
9.3 Asia-Pacific Artificial Tissue Heart Valve Market Size by Region
9.3.1 Asia-Pacific Artificial Tissue Heart Valve Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artificial Tissue Heart Valve Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artificial Tissue Heart Valve Sales by Type (2017-2028)
10.2 South America Artificial Tissue Heart Valve Sales by Application (2017-2028)
10.3 South America Artificial Tissue Heart Valve Market Size by Country
10.3.1 South America Artificial Tissue Heart Valve Sales in Volume by Country (2017-2028)
10.3.2 South America Artificial Tissue Heart Valve Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artificial Tissue Heart Valve Sales by Type (2017-2028)
11.2 Middle East & Africa Artificial Tissue Heart Valve Sales by Application (2017-2028)
11.3 Middle East & Africa Artificial Tissue Heart Valve Market Size by Country
11.3.1 Middle East & Africa Artificial Tissue Heart Valve Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artificial Tissue Heart Valve Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artificial Tissue Heart Valve and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artificial Tissue Heart Valve
12.3 Artificial Tissue Heart Valve Production Process
12.4 Artificial Tissue Heart Valve Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artificial Tissue Heart Valve Typical Distributors
13.3 Artificial Tissue Heart Valve Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---